Repligen Corporation Logo

Repligen Corporation

RGEN

(1.2)
Stock Price

144,46 USD

-0.13% ROA

-1.04% ROE

-3969.2x PER

Market Cap.

7.561.997.630,00 USD

30.17% DER

0% Yield

-3.36% NPM

Repligen Corporation Stock Analysis

Repligen Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Repligen Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (26.71%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ROA (8.9%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

3 DER

The stock maintains a fair debt to equity ratio (90%), indicating a reasonable balance between the money it owes and the ownership it possesses.

4 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (1.408) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

5 PBV

The stock's elevated P/BV ratio (18.09x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Repligen Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Repligen Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Repligen Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Repligen Corporation Revenue
Year Revenue Growth
1986 3.600.000
1987 3.700.000 2.7%
1988 10.200.000 63.73%
1989 8.500.000 -20%
1990 12.700.000 33.07%
1991 7.600.000 -67.11%
1992 11.700.000 35.04%
1993 27.300.000 57.14%
1994 26.800.000 -1.87%
1995 16.900.000 -58.58%
1996 10.900.000 -55.05%
1997 3.800.000 -186.84%
1998 2.400.000 -58.33%
1999 2.600.000 7.69%
2000 3.450.596 24.65%
2001 2.346.698 -47.04%
2002 4.301.565 45.45%
2003 7.771.781 44.65%
2004 6.914.341 -12.4%
2005 9.360.309 26.13%
2006 12.911.404 27.5%
2007 14.074.239 8.26%
2008 19.296.281 27.06%
2009 29.361.521 34.28%
2010 20.971.069 -40.01%
2011 27.291.024 23.16%
2012 62.266.536 56.17%
2013 68.169.623 8.66%
2014 63.548.349 -7.27%
2015 83.537.000 23.93%
2016 104.541.000 20.09%
2017 141.236.000 25.98%
2018 194.032.000 27.21%
2019 270.245.000 28.2%
2020 366.260.000 26.21%
2021 670.534.000 45.38%
2022 801.536.000 16.34%
2023 564.768.000 -41.92%
2023 638.764.000 11.58%
2024 616.292.000 -3.65%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Repligen Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 31.000.000 100%
1996 12.300.000 -152.03%
1997 1.400.000 -778.57%
1998 1.400.000 0%
1999 1.800.000 22.22%
2000 3.753.908 52.05%
2001 5.786.392 35.13%
2002 5.360.720 -7.94%
2003 5.226.524 -2.57%
2004 6.483.925 19.39%
2005 5.036.766 -28.73%
2006 5.163.098 2.45%
2007 5.924.439 12.85%
2008 7.240.812 18.18%
2009 12.771.573 43.31%
2010 14.159.721 9.8%
2011 12.528.819 -13.02%
2012 10.489.811 -19.44%
2013 7.340.698 -42.9%
2014 5.608.693 -30.88%
2015 5.740.000 2.29%
2016 7.355.000 21.96%
2017 8.672.000 15.19%
2018 15.768.000 45%
2019 19.450.000 18.93%
2020 20.182.000 3.63%
2021 34.274.000 41.12%
2022 43.936.000 21.99%
2023 42.308.000 -3.85%
2023 42.606.000 0.7%
2024 41.164.000 -3.5%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Repligen Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 4.597.085 100%
2006 5.417.339 15.14%
2007 6.360.292 14.83%
2008 10.173.400 37.48%
2009 5.933.090 -71.47%
2010 7.071.859 16.1%
2011 8.018.851 11.81%
2012 0 0%
2013 12.701.195 100%
2014 17.154.555 25.96%
2015 24.699.000 30.55%
2016 30.853.000 19.95%
2017 51.509.000 40.1%
2018 65.692.000 21.59%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Repligen Corporation EBITDA
Year EBITDA Growth
1986 -3.100.000
1987 11.500.000 126.96%
1988 -2.200.000 622.73%
1989 -2.800.000 21.43%
1990 -1.800.000 -55.56%
1991 -10.100.000 82.18%
1992 -11.700.000 13.68%
1993 -9.600.000 -21.88%
1994 -16.800.000 42.86%
1995 -6.400.000 -162.5%
1996 -2.800.000 -128.57%
1997 -400.000 -600%
1998 -600.000 33.33%
1999 -200.000 -200%
2000 -3.639.912 94.51%
2001 -9.109.395 60.04%
2002 -6.437.278 -41.51%
2003 -4.849.508 -32.74%
2004 -7.031.007 31.03%
2005 -4.582.856 -53.42%
2006 -1.991.068 -130.17%
2007 -2.233.844 10.87%
2008 -5.504.808 59.42%
2009 4.957.331 211.04%
2010 -4.387.682 212.98%
2011 1.300.457 437.4%
2012 11.406.149 88.6%
2013 22.853.783 50.09%
2014 12.951.067 -76.46%
2015 17.402.000 25.58%
2016 18.356.000 5.2%
2017 13.318.000 -37.83%
2018 26.250.000 49.26%
2019 35.769.000 26.61%
2020 69.609.000 48.61%
2021 171.946.000 59.52%
2022 184.595.000 6.85%
2023 -116.192.000 258.87%
2023 131.390.999 188.43%
2024 80.864.000 -62.48%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Repligen Corporation Gross Profit
Year Gross Profit Growth
1986 1.000.000
1987 -700.000 242.86%
1988 3.000.000 123.33%
1989 900.000 -233.33%
1990 2.200.000 59.09%
1991 8.200.000 73.17%
1992 11.900.000 31.09%
1993 27.800.000 57.19%
1994 25.300.000 -9.88%
1995 18.000.000 -40.56%
1996 10.800.000 -66.67%
1997 3.500.000 -208.57%
1998 2.100.000 -66.67%
1999 2.200.000 4.55%
2000 2.668.363 17.55%
2001 1.223.701 -118.06%
2002 2.308.831 47%
2003 4.291.340 46.2%
2004 3.665.964 -17.06%
2005 5.472.507 33.01%
2006 9.360.543 41.54%
2007 10.459.402 10.51%
2008 13.136.036 20.38%
2009 22.584.647 41.84%
2010 15.464.899 -46.04%
2011 20.173.599 23.34%
2012 35.096.289 42.52%
2013 43.006.324 18.39%
2014 35.526.315 -21.05%
2015 48.286.000 26.43%
2016 57.424.000 15.91%
2017 74.186.000 22.59%
2018 108.079.000 31.36%
2019 151.146.000 28.49%
2020 209.626.000 27.9%
2021 391.254.000 46.42%
2022 455.706.000 14.14%
2023 146.232.000 -211.63%
2023 284.247.000 48.55%
2024 275.092.000 -3.33%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Repligen Corporation Net Profit
Year Net Profit Growth
1986 -1.400.000
1987 -20.700.000 93.24%
1988 300.000 7000%
1989 -3.300.000 109.09%
1990 -2.400.000 -37.5%
1991 -5.700.000 57.89%
1992 -12.800.000 55.47%
1993 -11.300.000 -13.27%
1994 -19.500.000 42.05%
1995 -32.000.000 39.06%
1996 -11.500.000 -178.26%
1997 -500.000 -2200%
1998 -800.000 37.5%
1999 -2.500.000 68%
2000 -3.816.383 34.49%
2001 -5.278.867 27.7%
2002 -4.460.617 -18.34%
2003 -4.537.072 1.69%
2004 -9.550.860 52.5%
2005 -2.983.574 -220.11%
2006 696.860 528.15%
2007 -889.263 178.36%
2008 37.106.514 102.4%
2009 5.746.028 -545.78%
2010 -4.063.844 241.39%
2011 -43.509 -9240.24%
2012 14.156.037 100.31%
2013 16.093.155 12.04%
2014 8.170.214 -96.97%
2015 9.345.000 12.57%
2016 11.681.000 20%
2017 28.353.000 58.8%
2018 16.617.000 -70.63%
2019 21.411.000 22.39%
2020 59.926.000 64.27%
2021 128.291.000 53.29%
2022 185.959.000 31.01%
2023 72.688.000 -155.83%
2023 41.577.000 -74.83%
2024 13.284.000 -212.99%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Repligen Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 -4 100%
1988 0 0%
1989 0 0%
1990 0 0%
1991 -1 0%
1992 -1 100%
1993 -1 0%
1994 -2 100%
1995 -2 50%
1996 -1 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 1 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 1 100%
2021 2 50%
2022 3 33.33%
2023 1 -200%
2023 1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Repligen Corporation Free Cashflow
Year Free Cashflow Growth
1991 -6.800.000
1992 -9.900.000 31.31%
1993 -20.100.000 50.75%
1994 -24.800.000 18.95%
1995 -15.200.000 -63.16%
1996 -9.800.000 -55.1%
1997 -3.600.000 -172.22%
1998 -800.000 -350%
1999 -1.500.000 46.67%
2000 -3.351.756 55.25%
2001 -4.805.028 30.24%
2002 -5.062.143 5.08%
2003 -6.341.261 20.17%
2004 -6.026.142 -5.23%
2005 -847.935 -610.68%
2006 -320.111 -164.89%
2007 -921.047 65.24%
2008 37.364.016 102.47%
2009 4.967.145 -652.22%
2010 -3.045.703 263.09%
2011 2.707.097 212.51%
2012 12.175.961 77.77%
2013 21.295.191 42.82%
2014 12.798.751 -66.38%
2015 12.425.000 -3.01%
2016 3.196.000 -288.77%
2017 11.997.000 73.36%
2018 18.733.000 35.96%
2019 44.062.000 57.48%
2020 36.281.000 -21.45%
2021 47.740.000 24%
2022 38.737.000 -23.24%
2023 24.545.000 -57.82%
2023 74.930.000 67.24%
2024 34.790.000 -115.38%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Repligen Corporation Operating Cashflow
Year Operating Cashflow Growth
1991 -5.700.000
1992 -8.600.000 33.72%
1993 -1.900.000 -352.63%
1994 -24.800.000 92.34%
1995 -14.600.000 -69.86%
1996 -9.300.000 -56.99%
1997 -3.200.000 -190.63%
1998 -700.000 -357.14%
1999 -1.200.000 41.67%
2000 -3.134.500 61.72%
2001 -4.620.307 32.16%
2002 -4.754.172 2.82%
2003 -5.257.690 9.58%
2004 -5.718.369 8.06%
2005 -795.277 -619.04%
2006 415.384 291.46%
2007 405.482 -2.44%
2008 38.466.601 98.95%
2009 6.307.144 -509.89%
2010 -2.448.354 357.61%
2011 3.231.763 175.76%
2012 13.439.608 75.95%
2013 25.929.967 48.17%
2014 18.401.298 -40.91%
2015 15.053.000 -22.24%
2016 7.521.000 -100.15%
2017 17.451.000 56.9%
2018 32.770.000 46.75%
2019 67.216.000 51.25%
2020 62.625.000 -7.33%
2021 119.016.000 47.38%
2022 172.083.000 30.84%
2023 24.545.000 -601.09%
2023 113.918.000 78.45%
2024 42.190.000 -170.01%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Repligen Corporation Capital Expenditure
Year Capital Expenditure Growth
1991 1.100.000
1992 1.300.000 15.38%
1993 18.200.000 92.86%
1994 0 0%
1995 600.000 100%
1996 500.000 -20%
1997 400.000 -25%
1998 100.000 -300%
1999 300.000 66.67%
2000 217.256 -38.09%
2001 184.721 -17.61%
2002 307.971 40.02%
2003 1.083.571 71.58%
2004 307.773 -252.07%
2005 52.658 -484.48%
2006 735.495 92.84%
2007 1.326.529 44.55%
2008 1.102.585 -20.31%
2009 1.339.999 17.72%
2010 597.349 -124.32%
2011 524.666 -13.85%
2012 1.263.647 58.48%
2013 4.634.776 72.74%
2014 5.602.547 17.27%
2015 2.628.000 -113.19%
2016 4.325.000 39.24%
2017 5.454.000 20.7%
2018 14.037.000 61.15%
2019 23.154.000 39.38%
2020 26.344.000 12.11%
2021 71.276.000 63.04%
2022 133.346.000 46.55%
2023 0 0%
2023 38.988.000 100%
2024 7.400.000 -426.86%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Repligen Corporation Equity
Year Equity Growth
1986 -700.000
1987 21.200.000 103.3%
1988 25.000.000 15.2%
1989 21.900.000 -14.16%
1990 28.000.000 21.79%
1991 33.800.000 17.16%
1992 50.900.000 33.6%
1993 48.900.000 -4.09%
1994 46.700.000 -4.71%
1995 15.600.000 -199.36%
1996 4.800.000 -225%
1997 4.900.000 2.04%
1998 6.100.000 19.67%
1999 4.600.000 -32.61%
2000 35.090.402 86.89%
2001 30.891.165 -13.59%
2002 26.444.656 -16.81%
2003 24.549.868 -7.72%
2004 27.164.003 9.62%
2005 24.289.658 -11.83%
2006 25.433.029 4.5%
2007 25.538.298 0.41%
2008 64.106.854 60.16%
2009 69.123.431 7.26%
2010 66.120.376 -4.54%
2011 67.086.704 1.44%
2012 84.124.596 20.25%
2013 103.886.102 19.02%
2014 -80.887.208 228.43%
2015 122.748.000 165.9%
2016 -59.861.000 305.06%
2017 -31.508.000 -89.99%
2018 -15.568.000 -102.39%
2019 5.843.000 366.44%
2020 65.769.000 91.12%
2021 1.750.067.000 96.24%
2022 397.272.000 -340.52%
2023 464.337.000 14.44%
2023 1.971.203.000 76.44%
2024 1.986.362.000 0.76%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Repligen Corporation Assets
Year Assets Growth
1986 10.300.000
1987 23.000.000 55.22%
1988 27.500.000 16.36%
1989 24.700.000 -11.34%
1990 31.400.000 21.34%
1991 37.100.000 15.36%
1992 54.200.000 31.55%
1993 63.500.000 14.65%
1994 59.600.000 -6.54%
1995 31.300.000 -90.42%
1996 9.200.000 -240.22%
1997 5.600.000 -64.29%
1998 6.500.000 13.85%
1999 5.200.000 -25%
2000 36.287.487 85.67%
2001 32.147.989 -12.88%
2002 29.111.415 -10.43%
2003 26.793.256 -8.65%
2004 29.614.870 9.53%
2005 27.607.132 -7.27%
2006 28.599.341 3.47%
2007 29.075.883 1.64%
2008 68.839.707 57.76%
2009 73.754.742 6.66%
2010 71.419.963 -3.27%
2011 72.293.990 1.21%
2012 97.010.163 25.48%
2013 118.644.904 18.23%
2014 -65.425.961 281.34%
2015 146.237.000 144.74%
2016 288.913.000 49.38%
2017 120.408.000 -139.95%
2018 139.450.000 13.66%
2019 1.400.113.000 90.04%
2020 1.902.887.000 26.42%
2021 2.358.354.000 19.31%
2022 2.524.658.000 6.59%
2023 2.514.129.000 -0.42%
2023 2.824.411.000 10.99%
2024 2.861.924.000 1.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Repligen Corporation Liabilities
Year Liabilities Growth
1986 11.000.000
1987 1.800.000 -511.11%
1988 2.500.000 28%
1989 2.800.000 10.71%
1990 3.400.000 17.65%
1991 3.300.000 -3.03%
1992 3.300.000 0%
1993 14.600.000 77.4%
1994 12.900.000 -13.18%
1995 15.700.000 17.83%
1996 4.400.000 -256.82%
1997 700.000 -528.57%
1998 400.000 -75%
1999 600.000 33.33%
2000 1.197.085 49.88%
2001 1.256.824 4.75%
2002 2.666.759 52.87%
2003 2.243.388 -18.87%
2004 2.450.867 8.47%
2005 3.317.474 26.12%
2006 3.166.312 -4.77%
2007 3.537.585 10.5%
2008 4.732.853 25.25%
2009 4.631.311 -2.19%
2010 5.299.587 12.61%
2011 5.207.286 -1.77%
2012 12.885.567 59.59%
2013 14.758.802 12.69%
2014 15.461.247 4.54%
2015 23.489.000 34.18%
2016 120.149.000 80.45%
2017 151.916.000 20.91%
2018 155.018.000 2%
2019 340.345.000 54.45%
2020 373.737.000 8.93%
2021 608.287.000 38.56%
2022 613.958.000 0.92%
2023 525.572.000 -16.82%
2023 853.208.000 38.4%
2024 875.562.000 2.55%

Repligen Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
10.78
Net Income per Share
-0.03
Price to Earning Ratio
-3969.2x
Price To Sales Ratio
12.55x
POCF Ratio
48.62
PFCF Ratio
63.41
Price to Book Ratio
3.8
EV to Sales
12.44
EV Over EBITDA
285.13
EV to Operating CashFlow
48.3
EV to FreeCashFlow
62.85
Earnings Yield
-0
FreeCashFlow Yield
0.02
Market Cap
7,56 Bil.
Enterprise Value
7,50 Bil.
Graham Number
5.22
Graham NetNet
16.65

Income Statement Metrics

Net Income per Share
-0.03
Income Quality
-81.64
ROE
-0
Return On Assets
-0.01
Return On Capital Employed
-0
Net Income per EBT
7.94
EBT Per Ebit
0.5
Ebit per Revenue
-0.01
Effective Tax Rate
-6.94

Margins

Sales, General, & Administrative to Revenue
0.1
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.47
Operating Profit Margin
-0.01
Pretax Profit Margin
-0
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.16
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.78
Free CashFlow per Share
2.13
Capex to Operating CashFlow
0.23
Capex to Revenue
0.06
Capex to Depreciation
0.51
Return on Invested Capital
-0
Return on Tangible Assets
-0
Days Sales Outstanding
74.68
Days Payables Outstanding
21.53
Days of Inventory on Hand
196.19
Receivables Turnover
4.89
Payables Turnover
16.95
Inventory Turnover
1.86
Capex per Share
0.64

Balance Sheet

Cash per Share
28,96
Book Value per Share
35,54
Tangible Book Value per Share
11.11
Shareholders Equity per Share
35.54
Interest Debt per Share
10.86
Debt to Equity
0.3
Debt to Assets
0.21
Net Debt to EBITDA
-2.52
Current Ratio
6.65
Tangible Asset Value
0,62 Bil.
Net Current Asset Value
0,28 Bil.
Invested Capital
2686086000
Working Capital
0,98 Bil.
Intangibles to Total Assets
0.48
Average Receivables
0,12 Bil.
Average Payables
0,02 Bil.
Average Inventory
194280500
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Repligen Corporation Dividends
Year Dividends Growth

Repligen Corporation Profile

About Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

CEO
Mr. Olivier Loeillot
Employee
1.783
Address
Building 1
Waltham, 02453

Repligen Corporation Executives & BODs

Repligen Corporation Executives & BODs
# Name Age
1 Ms. Kimberly A. Cornwell
Global Head of Legal
70
2 Mr. Anthony J. Hunt
Executive Chair
70
3 Mr. Ralf Kuriyel
Senior Vice President of Research & Development
70
4 Mr. James R. Bylund
Chief Operating Officer
70
5 Ms. Sondra S. Newman
Global Head of Investor Relations
70
6 Mr. Neil Whitfield
Vice President & Global Head of Sales
70
7 Mr. Olivier Loeillot
President, Chief Executive Officer & Director
70
8 Ms. Teresa Ferragamo
Senior Director of Marketing
70
9 Mr. Jason K. Garland
Chief Financial Officer & Chief Compliance Officer
70
10 Mr. Keith Lee Robinson
Chief Information Officer
70

Repligen Corporation Competitors